Verve Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Verve Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Verve Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Verve Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $195k | 40k | 4.86 |
| 2024-06-30 | $144k | 29k | 4.91 |
| 2024-03-31 | $337k | 25k | 13.29 |
| 2023-12-31 | $276k | 20k | 13.96 |
| 2023-09-30 | $243k | 18k | 13.26 |
| 2023-06-30 | $317k | 17k | 18.79 |
| 2023-03-31 | $223k | 15k | 14.45 |
| 2022-12-31 | $286k | 15k | 19.32 |
| 2021-12-31 | $220k | 6.0k | 36.86 |
| 2021-06-30 | $41M | 685k | 60.25 |